日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumour-suppressive function of SIRT4 in human colorectal cancer

SIRT4 在人类结直肠癌中的肿瘤抑制作用

M Miyo, H Yamamoto, M Konno, H Colvin, N Nishida, J Koseki, K Kawamoto, H Ogawa, A Hamabe, M Uemura, J Nishimura, T Hata, I Takemasa, T Mizushima, Y Doki, M Mori, H Ishii

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

曲妥珠单抗联合 S-1 加顺铂治疗 HER2 阳性胃癌的 II 期研究 (HERBIS-1)

Kurokawa, Y; Sugimoto, N; Miwa, H; Tsuda, M; Nishina, S; Okuda, H; Imamura, H; Gamoh, M; Sakai, D; Shimokawa, T; Komatsu, Y; Doki, Y; Tsujinaka, T; Furukawa, H

CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma

CD10 作为头颈部鳞状细胞癌治疗耐药性和癌症干细胞的新标志物

T Fukusumi, H Ishii, M Konno, T Yasui, S Nakahara, Y Takenaka, Y Yamamoto, S Nishikawa, Y Kano, H Ogawa, S Hasegawa, A Hamabe, N Haraguchi, Y Doki, M Mori, H Inohara

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer

Lin28 高表达与食管癌患者的肿瘤侵袭性和不良预后有关

R Hamano, H Miyata, M Yamasaki, K Sugimura, K Tanaka, Y Kurokawa, K Nakajima, S Takiguchi, Y Fujiwara, M Mori, Y Doki

Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma

PFTK1 过表达预示着食管鳞状细胞癌患者对化疗的耐药性

H Miyagaki ,M Yamasaki, H Miyata, T Takahashi, Y Kurokawa, K Nakajima, S Takiguchi, Y Fujiwara, H Ishii, F Tanaka, M Mori, Y Doki